Award winning
MicroBioSensor
announces plans following
£1.4m investment
A University spin-out behind a medical
device designed to detect life threatening
infections will kick off its first clinical
trial next year following a £1.4 million
investment boost.
More
University skin
specialist spin-out
AIMs high with
£4.5M float
Skin health company,
SkinBioTherapeutics
(AIM:SBTX) will focus
on developing and
commercialising its SkinBiotix
®
technology platform after
making a stunning debut on
the London stock market.
More
